We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MODN
10276
DELISTED
MODEL N, INC.
MODN
-42,828
Closed -$1.22M
BRSH
10277
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
-48,883
Closed -$2.54K
DMTK
10278
DELISTED
DermTech, Inc. Common Stock
DMTK
-1,206
Closed -$846
VCXB.WS
10279
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
-351
Closed -$11
OMIC
10280
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
-73,646
Closed -$1.14M
HGAS
10281
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
-21,253
Closed -$29.1K
HGASW
10282
DELISTED
Global Gas Corporation Warrant
HGASW
-519
Closed -$22
TARO
10283
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
-31,317
Closed -$1.33M
FLFVR
10284
DELISTED
Feutune Light Acquisition Corporation Right
FLFVR
-1
Closed
ADTHW
10285
DELISTED
AdTheorent Holding Co Warrants
ADTHW
-88
Closed -$13
APCA
10286
DELISTED
AP Acquisition Corp
APCA
-2,106
Closed -$23.8K
ADTH
10287
DELISTED
AdTheorent Holding Co
ADTH
-45,020
Closed -$145K
GMFI
10288
DELISTED
Aetherium Acquisition Corp
GMFI
-2
Closed -$22
TGAN
10289
DELISTED
Transphorm, Inc. Common Stock
TGAN
-331,654
Closed -$1.63M
GMFIW
10290
DELISTED
Aetherium Acquisition Corp Warrant
GMFIW
-60
Closed -$4
GMFIU
10291
DELISTED
Aetherium Acquisition Corp Unit
GMFIU
-10
Closed -$108
FBGX
10292
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
-67
Closed -$56.5K
TDCX
10293
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
-417
Closed -$2.99K
ARTLW
10294
DELISTED
Artelo Biosciences, Inc. Warrant
ARTLW
-4,697
Closed -$75
SCPX
10295
DELISTED
Scorpius Holdings, Inc.
SCPX
-41
Closed -$26.5K
AQNU
10296
DELISTED
Algonquin Power & Utilities Corp Units
AQNU
-500
Closed -$10.7K
SNPO
10297
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
-20,888
Closed -$180K
THMO
10298
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
-6,817
Closed -$4.87K
CACG
10299
DELISTED
Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF
CACG
-44,315
Closed -$2.31M
DCPH
10300
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-166,438
Closed -$2.62M

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.